Rutgers Cancer Institute of New Jersey Expert Available for Comment on Proton Therapy for Breast Cancer

New Brunswick, N.J., August 23, 2021 – Proton therapy is a type of radiation therapy treatment that targets a tumor in a very precise way, emerging as a unique modality for breast cancer due to the ability to minimize exposure surrounding healthy…

Proton therapy induces biologic response to attack treatment-resistant cancers

Mayo Clinic researchers have developed a novel proton therapy technique to more specifically target cancer cells that resist other forms of treatment. The technique is called LEAP, an acronym for “biologically enhanced particle therapy.” The findings are published today in Cancer Research, the journal of the American Association for Cancer Research.

Hackensack Meridian Health Welcomes Radiation Oncologist with Fellowship Training in Proton Therapy

Radiation oncologist Nicholas DeNunzio, M.D., Ph.D., has joined Hackensack Meridian Health. Dr. DeNunzio has deep expertise and training in the use of standard radiation therapies, including proton therapy, which allows for the safe and precise delivery of higher doses of radiation therapy while reducing radiation exposure to surrounding tissues.

3 Awards Will Support Accelerator R&D for Medical Treatment, Miniaturization, and Machine Learning

U.S. Department of Energy awards announced in July will advance Lawrence Berkeley National Laboratory (Berkeley Lab) R&D to develop a more effective and compact particle-beam system for cancer treatment, improve particle-beam performance using artificial intelligence, and develop a high-power, rapid-fire laser system for both tabletop and large-scale applications.

Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery

Investigators at Rutgers Cancer Institute of New Jersey conducted a retrospective review of patients treated with proton therapy following breast-conserving surgery and found acceptable toxicity rates along with good-to-excellent patient-reported cosmetic outcomes.

New research suggests proton radiation therapy can benefit patients with challenging liver tumors

Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. The studies were published in the International Journal of Radiation Oncology • Biology • Physics, the flagship scientific journal of the American Society for Radiation Oncology (ASTRO).